chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Fever; Joint pain; Muscle pain; Not feeling good; Chills; Tiredness; This is a spontaneous report from a contactable consumer. A 55-years-old male patient received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0150; Expiration Date: 31Aug2021) dose 1 intramuscular, administered in Arm Right on 01Apr2021 as DOSE 1, SINGLE for covid-19 immunisation (at the age 55 years). Medical history and concomitant medications were not reported. The patient experienced headache, fever, joint pain, muscle pain, not feeling good, chills, tiredness on 03Apr2021. When probed for concern, Reporter stated, they received the Pfizer vaccine a week ago Thursday. and my husband, we got it on Thursday (Date confirmed as 01Apr2021) and on Saturday (Date confirmed as 03Apr2021) was not feeling good, fever, he had almost the tiredness, the headache, the muscle pain, the chills, the joint pain, Fever and just feeling unwell that was everything left he could possibly feel. Now he felt horrible Saturday, Sunday was not bad then Monday, Tuesday and Wednesday, the day he is finally feeling better but he was not been able to work because it was so bad he not back to work. When paraphrased the concern, Reporter stated, Yes, he never missed his work. When told about the Pfizer medical information department, reporter stated, all he wanted to do was to knew if it was normal. Reporter stated, He was but today he is feeling better. He is not able to work from 05Apr2021 to 08Apr2021 (Confirmed as 8Apr2021), about concomitant medication Reporter stated, No, he does not take anything but he take something over the counter for muscle ache because he works, that was it. Therapy date for second shot of Pfizer vaccine was scheduled on 22Apr2021. When probed for lab test, Consumer Stated No. Therapeutic measures were taken included Tylenol and Motrin for pain (as a result of joint pain and muscle pain) and he would take 2 of each every 6 hours. It was 500 mg on the Tylenol. The clinical outcome of the events was recovered on 08Aug2021.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
difficulty swallowing; fever; headache; pain at the injection site; This is a spontaneous report received from a contactable consumer (patient). This 29-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 12Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 13Mar2021, the patient experienced having difficulty swallowing. She had to try really hard. She woke up with a fever, headache, and pain at the injection site. She felt fine on 12Mar2021. The outcomes of having difficulty swallowing, fever, headache, and pain at the injection site were unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
1SEP97 830PM pt devel rash on upper chest, abd & hands w/severe itching;denied fever, n/v & arthralgia;some SOB noted on visit to clinic on 2SEP97;seen @ MD ?serum sickness;
Lethargy, mild fever (101-102*), soreness at injection site, congestion and more labored breathing while sleeping.
unable to use his left arm fully; sore arm; arm numbness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HYPOAESTHESIA (arm numbness) and LIMB DEFORMITY (unable to use his left arm fully) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history information provided by the reporter.  The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and HYPOAESTHESIA (arm numbness). On an unknown date, the patient experienced LIMB DEFORMITY (unable to use his left arm fully). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (sore arm) and HYPOAESTHESIA (arm numbness) had not resolved and LIMB DEFORMITY (unable to use his left arm fully) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not given. Treatment included Ibuprofen
Headache; Fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN) and Statin drugs for an unknown indication.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 09-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, FATIGUE (Fatigue) and CHILLS (chills) outcome was unknown.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 02-JAN-2016 at 01:08, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperature were 8.6 and 8.0 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
No adverse event reported. This is inform that patient received a second booster of the moderna bivalent after its beyond use date. Vial was moved to fridge on 4/3/2023 and patient received vaccine on 5/10/23
Patient reported burning pain, numbness of the arm, tingling, shaking, weakness, chest pain., and back pain. She said she could not move her arm for 4 days. She also said she had swelling in the chest and arm.
Patient was inadvertently administered a second booster dose of vaccine when patient did not meet criteria for a second dose. Patient was notified immediately after error was discovered after patient left the clinic. Patient stated that she was not concerened about recieving an extra dose of vaccine. Denies any side effects.. Agreed to monitor for any future side effects and contact the clinic or primary care provider.
This spontaneous report as received from a physician refers to a 9 weeks old female patient. On 17-JUL-2012, the patient was vaccinated with dose 1 of ROTATEQ 2 ml orally (lot # 0059AE, exp date not reported). No other co-suspects were reported. No concomitant medications were reported. On approximately 21-JUL-2012, 4-5 days after the 1st dose, the patient experienced bloody diarrhoea. The physician was called due to the event. There was no treatment given for the event. There was no labs/diagnostic studies performed. The outcome of bloody diarrhoea was reported as recovered. The patient had no problem with the second dose, and had not yet received the third. The relationship between the event and ROTATEQ, Oral, was not reported. Additional information has been requested.
Local: itching x 4-5 days; on day of vaccine, experienced swelling of arm from upper arm to elbow and experienced pain at elbow lasting several hours; swelling at site lasted about 3 days; usual progression to pustules-scab; determined to be a major reaction after approximately 1 week. Systemic: day after vaccine, experienced fever, chills, headache, poor appetite, muscle aches, and swollen glands in neck, which lasted x 4-6 hrs. On 2/26/03 noted palpitations, which lasted about a minute. Says she took a deep breath, and her heartbeat went back into a regular rhythm. Significant cardiac symptoms noted around 4/28/03. Pt was evaluated by a physician for a hip injury she experienced status-post a fall approximately 4 days prior. She was found to be "not fit for duty." She then took a few days to recover before flying to pick up her car. she said she didn't feel "normal." Again, she took a few days to rest before driving back. Once she returned, she saw a physician for evaluation for her hip pain. He ordered physical therapy, and prescribed ibuprofen and a Medrol dosage pack. She did not take the Ibuprofen, but did complete the 5-day course of steroids. She denies specific cardiac-related complaints until the last week in April, when she noted swelling of her feet. Three days later, on 5/1/03, she began experiencing continuous heart palpitations accompanied by mild dyspnea, weakness, and vague chest discomfort. She was seen in the ER, and then admitted to hospital. Her symptoms resolved the next day after treatment with medications. On 5/6/03, she was discharged with the diagnosis of atrial fibrillation and congestive heart failure. She will see her cardiologist in 1 week.  Current problem: new onset atrial fibrillation, temporally associated with 2nd smallpox vaccine. New onset congestive heart failure. Newly diagnosed HTN. Left hip injury status-post fall, recovering.
2/22/21 Patient presented to ED w/ cough, SOB and fatigue. Initial RA pulse ox 86%. She was admitted and was found to have COVID and was admitted. She was treated with med nebs and prednisone. She was maintained on O2 per nasal canula until 3/2/21. She reportedly had been having symptoms for 2 wees prior to admission so Remdesivir was deferred. Hospital course prolonged by very slow progress with rehab and she was discharged to rehab on 3/3.
Urinating a lot after first shot; Headache after first shot; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (Urinating a lot after first shot) and HEADACHE (Headache after first shot) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced POLLAKIURIA (Urinating a lot after first shot) and HEADACHE (Headache after first shot). At the time of the report, POLLAKIURIA (Urinating a lot after first shot) and HEADACHE (Headache after first shot) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient states that she does not have a history of urinary tract infection. No concomitant medications was reported. Treatment medications was not provided.   This case was linked to MOD-2022-437614, MOD-2022-437623 (Patient Link).
pt recv vax 11APR96 between 5 & 7PM;no problems that evening or noc;slept OK;began to fuss & cry in AM;quite constant;took temp ax @ noon 103.9;no redness, warmth etc @ inj site;to ER 12APR96 t104 given Advil & Amoxicillin dx w/URI
rush in the brain after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (rush in the brain after the first dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (rush in the brain after the first dose). At the time of the report, HEAD DISCOMFORT (rush in the brain after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has heart issues. No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-403018 (Patient Link).
Respiratory Congestion; Experience pain; Blood pressure went high; 104.2 Degrees Farenheit fever; Arthritic pain; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY TRACT CONGESTION (Respiratory Congestion), PAIN (Experience pain), HYPERTENSION (Blood pressure went high), PYREXIA (104.2 Degrees Farenheit fever) and ARTHRALGIA (Arthritic pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 091D21H, 013120A. and 013C20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (allergies to almost everything), Peanut allergy, Shellfish allergy (shrimp), Asthma and Swelling. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA ALLERGY), PREGABALIN (LYRICA), MONTELUKAST SODIUM (SINGULAIR) and XYLOMETAZOLINE HYDROCHLORIDE (NASAL SPRAY II) for Allergy, METOPROLOL and AMLODIPINE for Blood pressure, IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, HCTZ for Swelling.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced RESPIRATORY TRACT CONGESTION (Respiratory Congestion), PAIN (Experience pain), HYPERTENSION (Blood pressure went high), PYREXIA (104.2 Degrees Farenheit fever) and ARTHRALGIA (Arthritic pain). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) ongoing since an unknown date for Pain, at a dose of 500 milligram once a day. At the time of the report, RESPIRATORY TRACT CONGESTION (Respiratory Congestion), PAIN (Experience pain), HYPERTENSION (Blood pressure went high), PYREXIA (104.2 Degrees Fahrenheit fever) and ARTHRALGIA (Arthritic pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.2 degrees fahrenheit. (High) 104.2 Degrees Fahrenheit..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient tried to consult with pulmonologist regarding the side effects and was told to continue taking Tylenol. Patient is taking Tylenol 500mg once a day for pain.  Patient has been taking Metoprolol for 5 years, amlodipine since February this year, HCTZ for 10 years.   This case was linked to MOD-2022-540053 (Patient Link).
subjective tongue tingling, "heaviness". Flushed and mildly dizzy upon standing.
Had a little bit of pain with the first vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Jun2021 (Lot number: EW0178) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Celiacs", start date: 2018 (ongoing), notes: Verbatim: Celiacs diagnosed 2018, she doesn't take medication for it, she just avoids gluten; "COVID-19" (unspecified if ongoing), notes: She had COVID a year ago. The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "unknown", described as "Had a little bit of pain with the first vaccine". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Pain on left shoulder and cannot raise the arm; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (Pain on left shoulder and cannot raise the arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRALGIA (Pain on left shoulder and cannot raise the arm). At the time of the report, ARTHRALGIA (Pain on left shoulder and cannot raise the arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product used was not provided by the reporter. Patient reported he doesn't require any further follow-up.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: followup received but no new information was updated.
103 fever; severe chills; severe pain all over body; injection site arm swollen and immobile.
She tested positive on 08/19/2022 for COVID-19. On 10/05/2022 she was sent home from school because she had a fever of 100-102.5. The fever did not go away and has a fever for 3 months. In that time, we got referred to provider and ran multiple tests. The provider ruled out cancer and other diseases.
Eyes itchy, red, cough, about an hout later, wheeze, shortness of breath, about 15 minutes later fever started going up, nasty headache.  Went to bed at 9:00 P.M. and about 12:00 eyes stuck closed with matter.  Used hot water to wash them.  Very restless night and have spent the day in bed.  Up about 2:00 P.M. trying to get back to normal.
Wheezing/bronchitis, chest congestions, cough, low grade fever, stuffy nose. Prescribed breathing treatment, 5 days of steroids (prednisone), Flovent twice a day. Still having breathing problems and congestion as of 10/12/2010.
right ear itching and burning and then the skin started to crack; right ear itching and burning and then the skin started to crack; right ear itching and burning and then the skin started to crack; top of ear burning and very hot; This is a spontaneous report from a contactable consumer or other non hcp. A female consumer reported for a patient (son's wife's grandfather). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, batch/lot number was not reported, expiration date unknown) via an unspecified route of administration on an unspecified date as first dose, single for covid-19 immunization. Medical history and concomitant medications were not reported. It was reported that patient received first dose of vaccine and after that patient had right ear itching and burning and then the skin started to crack and top of ear burning and very hot. Reporter stated that the patient experienced the same adverse events like her. The outcome of the events was unknown.
I have rashes on the palm side of both forearms, on my chest and back. I also have a rash on my left hand near my thumb. They appear in the shape, size and color of a white pimple. Symptoms of Eczema without the severe itching. I think its important to note that I had the Shingrix vaccine 03/10/2020 & Flu shot 09/08/2020
Starting 5-6 days after administration of vaccine, employee experienced low grade fever, sore throat, joint/muscle aches, burning eyes, heart flutter/palpitation. Symptoms lasted for 2 days then resolved.
I was speaking with some workers that I had hired and all of a sudden I wasn't making any sense. I was saying words that didn't make sense. I've never experienced something like this. I just sat and waited for my wife. I mentioned I was having some issues. I also that a headache in the front of my head over my left eye. A sinus type of pressure.
Information has been received from a pharmacist referring to a 61-year-old female patient. The patient had no drug allergies. Her pertinent medical history and concomitant medication were not reported. On 28-NOV-2016, the patient was vaccinated with ZOSTAVAX lot # M001747 with expiration date of 07-APR-2017, subcutaneously (strength and dose were not reported). On an unspecified date in November 2016, the patient experienced a 5 centimeter area of erythema and a 13 centimeter raised area around the injection site. The patient was seen by an unspecified physician on 30-NOV-2016. There was no lab diagnostic study performed. At the time of reporting, the patient was not recovered from the events. The causality was not reported. Additional information has been requested.
This case was reported by a physician and described the occurrence of wrong vaccine administered in a 16-year-old subject of unspecified gender who was vaccinated with HAVRIX adult (GlaxoSmithKline). On an unspecified date, the subject received an unspecified dose of HAVRIX adult (0.5 ml, unknown route and injection site, batch number not provided) instead of HAVRIX Junior. No adverse event was reported.
its ischemic stroke; I was at store and passed out; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ISCHAEMIC STROKE (its ischemic stroke) and LOSS OF CONSCIOUSNESS (I was at store and passed out) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 020B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included AMLODIPINE, ROSUVASTATIN CALCIUM (CRESTOR), ROPINIROLE, CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]), FUROSEMIDE (LASIX [FUROSEMIDE]), QUETIAPINE FUMARATE (SEROQUEL), BUSPIRONE HYDROCHLORIDE (BUSPAR), ESTRADIOL and TRAZODONE for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced ISCHAEMIC STROKE (its ischemic stroke) (seriousness criteria hospitalization and medically significant) and LOSS OF CONSCIOUSNESS (I was at store and passed out) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on 27-May-2021 due to ISCHAEMIC STROKE. The patient was treated with ALTEPLASE ongoing since an unknown date at a dose of Activase Alteplase. At the time of the report, ISCHAEMIC STROKE (its ischemic stroke) and LOSS OF CONSCIOUSNESS (I was at store and passed out) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2021, Computerised tomogram: abnormal (abnormal) ischemic stroke.. On 27-May-2021, Magnetic resonance imaging: abnormal (abnormal) ischemic stroke..         Patient was in Emergency room for 3 days and 2 days in ICU. patient was shifted to room and  1 day in regular room. In emergency room patient was prescribed with Activase Alteplase for treatment along with her daily medication. Company comment: Very limited information regarding this events has been provided at this time.  Further information can't be requested.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Further information can't be requested.
This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. On 23-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.